BRPI0519476B8 - processo para a síntese de cefaclor e processo para obtenção de cefaclor - Google Patents
processo para a síntese de cefaclor e processo para obtenção de cefaclorInfo
- Publication number
- BRPI0519476B8 BRPI0519476B8 BRPI0519476A BRPI0519476A BRPI0519476B8 BR PI0519476 B8 BRPI0519476 B8 BR PI0519476B8 BR PI0519476 A BRPI0519476 A BR PI0519476A BR PI0519476 A BRPI0519476 A BR PI0519476A BR PI0519476 B8 BRPI0519476 B8 BR PI0519476B8
- Authority
- BR
- Brazil
- Prior art keywords
- cefaclor
- weight
- synthesis
- amount
- reaction
- Prior art date
Links
- QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 title abstract 8
- 229960005361 cefaclor Drugs 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 6
- 230000015572 biosynthetic process Effects 0.000 title abstract 3
- 238000003786 synthesis reaction Methods 0.000 title abstract 3
- OQSAFIZCBAZPMY-AWFVSMACSA-N (6r,7r)-7-azaniumyl-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound S1CC(Cl)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@H]21 OQSAFIZCBAZPMY-AWFVSMACSA-N 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000011541 reaction mixture Substances 0.000 abstract 2
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 238000002835 absorbance Methods 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
- C12P35/04—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by acylation of the substituent in the 7 position
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/58—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with a nitrogen atom, which is a member of a hetero ring, attached in position 7
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04106999 | 2004-12-27 | ||
EP04106999.8 | 2004-12-27 | ||
PCT/EP2005/057155 WO2006069984A2 (en) | 2004-12-27 | 2005-12-23 | Process for the synthesis of cefaclor |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0519476A2 BRPI0519476A2 (pt) | 2009-02-03 |
BRPI0519476B1 BRPI0519476B1 (pt) | 2020-12-22 |
BRPI0519476B8 true BRPI0519476B8 (pt) | 2021-05-25 |
Family
ID=35512770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0519476A BRPI0519476B8 (pt) | 2004-12-27 | 2005-12-23 | processo para a síntese de cefaclor e processo para obtenção de cefaclor |
Country Status (8)
Country | Link |
---|---|
US (1) | US8071330B2 (pt) |
EP (1) | EP1831390B1 (pt) |
JP (1) | JP5022913B2 (pt) |
KR (1) | KR101203287B1 (pt) |
CN (1) | CN101090978B (pt) |
BR (1) | BRPI0519476B8 (pt) |
MX (1) | MX2007007937A (pt) |
WO (1) | WO2006069984A2 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010072765A2 (en) * | 2008-12-23 | 2010-07-01 | Dsm Ip Assets B.V. | Mutant penicillin g acylases |
EP2723882B1 (en) | 2011-06-23 | 2019-05-01 | Centrient Pharmaceuticals Netherlands B.V. | Process for preparing 3'-thiosubstituted cephalosporins employing a penicillin g acylase |
WO2012175587A2 (en) | 2011-06-23 | 2012-12-27 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Novel crystalline cefoperazone intermediate |
CN102443014B (zh) * | 2011-12-29 | 2014-07-09 | 上海右手医药科技开发有限公司 | 3-氯头孢菌素衍生物及其合成方法与在头孢克洛制备中的应用 |
CN103571907B (zh) * | 2013-10-30 | 2016-01-13 | 苏州中联化学制药有限公司 | 一种酶法合成头孢克洛的分离及纯化方法 |
CN103757085B (zh) * | 2013-11-28 | 2016-06-15 | 湖南福来格生物技术有限公司 | 头孢克洛及其合成方法 |
CN103667418B (zh) * | 2013-12-18 | 2015-03-25 | 华北制药河北华民药业有限责任公司 | 高活性β-内酰胺抗生素合成用酶的高通量筛选方法 |
CN106222230A (zh) * | 2016-08-03 | 2016-12-14 | 广州白云山医药集团股份有限公司白云山化学制药厂 | 一种绿色酶法合成头孢克洛的方法 |
CN107523603B (zh) * | 2017-08-04 | 2020-12-29 | 长沙凯晓生物科技有限公司 | 一种酶法制备头孢克洛的方法 |
CN109266713A (zh) * | 2018-11-12 | 2019-01-25 | 齐鲁安替制药有限公司 | 一种适用于工业生产的头孢克洛的制备方法 |
CN110408670A (zh) * | 2019-08-19 | 2019-11-05 | 苏州盛达药业有限公司 | 一种酶催化合成头孢克洛的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1274658B (it) * | 1995-02-28 | 1997-07-18 | Acs Dobfar Spa | Procedimento enzimatico migliorato per la produzione di penicilline e cefalosporine |
AU718648B2 (en) * | 1996-11-05 | 2000-04-20 | Bristol-Myers Squibb Company | Mutant penicillin G acylases |
NL1007302C2 (nl) * | 1997-10-17 | 1999-04-20 | Dsm Nv | Werkwijze voor de bereiding van een ß-lactam antibioticum. |
AU2002358777A1 (en) | 2001-12-27 | 2003-07-15 | Dsm N.V. | Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase |
-
2005
- 2005-12-23 EP EP05850496.0A patent/EP1831390B1/en active Active
- 2005-12-23 JP JP2007548813A patent/JP5022913B2/ja not_active Expired - Fee Related
- 2005-12-23 MX MX2007007937A patent/MX2007007937A/es active IP Right Grant
- 2005-12-23 CN CN2005800450055A patent/CN101090978B/zh active Active
- 2005-12-23 BR BRPI0519476A patent/BRPI0519476B8/pt active IP Right Grant
- 2005-12-23 KR KR1020077017147A patent/KR101203287B1/ko active IP Right Grant
- 2005-12-23 WO PCT/EP2005/057155 patent/WO2006069984A2/en active Application Filing
- 2005-12-23 US US11/794,119 patent/US8071330B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MX2007007937A (es) | 2007-08-21 |
BRPI0519476B1 (pt) | 2020-12-22 |
JP5022913B2 (ja) | 2012-09-12 |
WO2006069984A3 (en) | 2007-04-12 |
EP1831390A2 (en) | 2007-09-12 |
JP2008525044A (ja) | 2008-07-17 |
KR20070090042A (ko) | 2007-09-04 |
CN101090978B (zh) | 2012-07-04 |
EP1831390B1 (en) | 2014-11-19 |
US8071330B2 (en) | 2011-12-06 |
CN101090978A (zh) | 2007-12-19 |
BRPI0519476A2 (pt) | 2009-02-03 |
US20080050771A1 (en) | 2008-02-28 |
KR101203287B1 (ko) | 2012-11-20 |
WO2006069984A2 (en) | 2006-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0519476B8 (pt) | processo para a síntese de cefaclor e processo para obtenção de cefaclor | |
BRPI0513517A (pt) | processo para a purificação de correntes de gás de co2 | |
BR0314770A (pt) | Processo para preparar pelo menos um produto de oxidação e/ou amoxidação parcial de propileno | |
BRPI0403234A (pt) | Negro-de-fumo | |
BRPI0400263A (pt) | Pneu com combinação de componentes de banda de rodagem e flanco de borracha de baixa emissão de hidrocarbonetos com limitações composicionais | |
BR0208461A (pt) | Tampão que apresenta ranhuras de forma espiralada | |
BRPI0608584B8 (pt) | métodos de recuperar um produto purificado | |
BR0309145A (pt) | Células das quais o genoma é modificado | |
BRPI0719147A8 (pt) | Processo para a produção de material suportado por óxido de rutênio e processo para a produção de cloro. | |
BRPI0509767A (pt) | fotocatalisador de dióxido de titánio contendo carbono e processo para sua fabricação | |
BRPI0513237A (pt) | hidrolisados de proteìna para diminuição de pressão sanguìnea | |
BRPI0506767A (pt) | processo para a produção de uma composição contendo 5'- ribonucleotìdeos e suas composições | |
BR0116903A (pt) | Métodos para produzir dióxido de titanio substancialmente isento de anatásio com a adição de halogeneto de silìcio | |
BR0308828A (pt) | Método de produção de um ou mais artigos viscoelásticos, e, artigo viscoelástico | |
BRPI0603365A (pt) | misturas de borracha | |
BRPI0600167A (pt) | processo para destilação de uma mistura de diisocianato-difenilimetanos isoméricos | |
BR9914483A (pt) | Negro-de-fumo, processo para produção do mesmo,bem como seu uso | |
BRPI0607265A2 (pt) | processo para produção de soluções de hidróxido de césio | |
BRPI0508044A (pt) | método para a produção de poliésteres altamente condensados no estado sólido e método para a produção de um corpo formado de poliéster | |
BRPI0501416A (pt) | Processo para produção de metil-hidróxi-alquil-celulose | |
BRPI0408568A (pt) | triidrato de amoxicilina | |
BR112013003992A2 (pt) | método de produção | |
ATE538184T1 (de) | Chromfreie, zinkarme, korrosionshemmende pigmentmischung, verfahren zu ihrer herstellung und ihre verwendung | |
WO2007119004A3 (fr) | Methode de diagnostic in vitro ou ex vivo de desordres psychiatriques et/ou de dysbioses intestinales | |
BRPI0412302A (pt) | processo para a preparação de cefradina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/12/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B25D | Requested change of name of applicant approved |
Owner name: CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. (NL) |
|
B25K | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication |
Owner name: CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. (NL) Free format text: RETIFICACAO DO DESPACHO (25.4) ? ALTERACAO DE NOME PUBLICADO NA RPI NO 2636, DE 13/07/2021, QUANTO AO NOME DO DEPOSITANTE NA AVERBACAO.ONDE SE LE: CENTRIENT PHARMACEUTICALS NETHERLANDS B.VLEIA-SE: CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. |